Cell and Molecular Biology Seminar Series
CMB Internal Seminar Series
Co-inhibition of Polo-like Kinase I (PLK1) and Mechanistic Target of Rapamycin (mTOR) as a Combinational Therapeutic Strategy in Angiosarcoma
Nimod Janson
Hanna Lab
November 12 (Wed) at noon in
Lily 1-117